TOPLINE:
Research from Korea provides additional evidence for the connection between COVID-19 and an increased risk for autoimmune conditions post-infection.
METHODOLOGY:
- In this retrospective study, researchers identified 354,527 individuals diagnosed with COVID-19 via polymerase chain reaction (PCR) testing from October 8, 2020 to December 31, 2021.
- Researchers compared the COVID-19 group to 6,134,940 healthy individuals who had no evidence of COVID-19 to quantify the risk for autoimmune and autoinflammatory connective tissue disorders.
- Patients were followed until diagnosis, death, or end of study period (December 31, 2021).